Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	CD8 receptor binding	HLA-A HLA-F HLA-G	2.00e-05	9	126	3	GO:0042610
GeneOntologyMolecularFunction	TAP complex binding	HLA-A HLA-F HLA-G	2.00e-05	9	126	3	GO:0062061
GeneOntologyMolecularFunction	TAP1 binding	HLA-A HLA-F HLA-G	2.85e-05	10	126	3	GO:0046978
GeneOntologyMolecularFunction	TAP2 binding	HLA-A HLA-F HLA-G	2.85e-05	10	126	3	GO:0046979
GeneOntologyMolecularFunction	TAP binding	HLA-A HLA-F HLA-G	2.85e-05	10	126	3	GO:0046977
GeneOntologyMolecularFunction	cyclin-dependent protein serine/threonine kinase activity	CDK20 CDK11A CDK2 CDK3	3.65e-05	30	126	4	GO:0004693
GeneOntologyMolecularFunction	cyclin-dependent protein kinase activity	CDK20 CDK11A CDK2 CDK3	3.65e-05	30	126	4	GO:0097472
GeneOntologyMolecularFunction	beta-2-microglobulin binding	HLA-A HLA-F HLA-G	5.18e-05	12	126	3	GO:0030881
GeneOntologyMolecularFunction	14-3-3 protein binding	HLA-A HLA-F HLA-G TMCC3	1.41e-04	42	126	4	GO:0071889
GeneOntologyMolecularFunction	natural killer cell lectin-like receptor binding	HLA-A HLA-F HLA-G	1.56e-04	17	126	3	GO:0046703
GeneOntologyMolecularFunction	T cell receptor binding	HLA-A HLA-F HLA-G	2.59e-04	20	126	3	GO:0042608
GeneOntologyMolecularFunction	MHC protein binding	HLA-A HLA-F LAG3 HLA-G	4.93e-04	58	126	4	GO:0042287
GeneOntologyMolecularFunction	MHC class I protein binding	HLA-A HLA-F HLA-G	1.06e-03	32	126	3	GO:0042288
GeneOntologyMolecularFunction	tRNA-specific adenosine deaminase activity	ADAT3 ADARB2	1.08e-03	8	126	2	GO:0008251
GeneOntologyMolecularFunction	cyclin binding	PTCH1 CDK2 CDK3	1.39e-03	35	126	3	GO:0030332
GeneOntologyBiologicalProcess	embryonic epithelial tube formation	CDK20 LIAS SIX4 PTCH1 PLXNB2 CELSR1 GDF7 HS2ST1 HECTD1	4.14e-07	159	121	9	GO:0001838
GeneOntologyBiologicalProcess	epithelial tube formation	CDK20 LIAS SIX4 PTCH1 PLXNB2 CELSR1 GDF7 HS2ST1 HECTD1	8.43e-07	173	121	9	GO:0072175
GeneOntologyBiologicalProcess	tube formation	CDK20 LIAS SIX4 PTCH1 PLXNB2 CELSR1 GDF7 HS2ST1 HECTD1	1.61e-06	187	121	9	GO:0035148
GeneOntologyBiologicalProcess	morphogenesis of embryonic epithelium	CDK20 LIAS SIX4 PTCH1 PLXNB2 CELSR1 GDF7 HS2ST1 HECTD1	1.84e-06	190	121	9	GO:0016331
GeneOntologyBiologicalProcess	antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent	HLA-A HLA-F HLA-G	1.08e-05	8	121	3	GO:0002485
GeneOntologyBiologicalProcess	neural tube formation	CDK20 LIAS PTCH1 PLXNB2 CELSR1 GDF7 HECTD1	1.42e-05	134	121	7	GO:0001841
GeneOntologyBiologicalProcess	regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction	PRR5L HLA-G OBSCN XDH HPSE IGF2 PLD2 HYAL2 PLXNB1 EPHA8	2.80e-05	334	121	10	GO:0051896
GeneOntologyBiologicalProcess	natural killer cell mediated cytotoxicity	HLA-A HLA-F LAG3 HLA-G IGF2 SLAMF7	3.61e-05	105	121	6	GO:0042267
GeneOntologyBiologicalProcess	epithelial tube morphogenesis	CDK20 TMEM67 LIAS SIX4 PTCH1 PLXNB2 CELSR1 GDF7 HS2ST1 CSMD1 HECTD1	3.84e-05	421	121	11	GO:0060562
GeneOntologyBiologicalProcess	natural killer cell mediated immunity	HLA-A HLA-F LAG3 HLA-G IGF2 SLAMF7	4.45e-05	109	121	6	GO:0002228
GeneOntologyBiologicalProcess	anatomical structure formation involved in morphogenesis	CDK20 LIAS MYOM1 NTF4 NTN3 CNTNAP1 HLA-G OBSCN RNF213 ADAMTS5 SIX4 PTCH1 PLXNB2 HPSE CELSR1 IGF2 GDF7 LDB1 HS2ST1 HECTD1 NOS1 VPS13B	4.69e-05	1483	121	22	GO:0048646
GeneOntologyBiologicalProcess	neural tube closure	CDK20 LIAS PTCH1 PLXNB2 CELSR1 HECTD1	5.45e-05	113	121	6	GO:0001843
GeneOntologyBiologicalProcess	tube closure	CDK20 LIAS PTCH1 PLXNB2 CELSR1 HECTD1	5.73e-05	114	121	6	GO:0060606
GeneOntologyBiologicalProcess	primary neural tube formation	CDK20 LIAS PTCH1 PLXNB2 CELSR1 HECTD1	7.62e-05	120	121	6	GO:0014020
GeneOntologyBiologicalProcess	regulation of natural killer cell mediated cytotoxicity	HLA-A HLA-F LAG3 HLA-G IGF2	8.47e-05	76	121	5	GO:0042269
GeneOntologyBiologicalProcess	phosphatidylinositol 3-kinase/protein kinase B signal transduction	PRR5L HLA-G OBSCN XDH HPSE IGF2 PLD2 HYAL2 PLXNB1 EPHA8	8.62e-05	382	121	10	GO:0043491
GeneOntologyBiologicalProcess	negative regulation of natural killer cell mediated cytotoxicity	HLA-A HLA-F HLA-G IGF2	8.75e-05	40	121	4	GO:0045953
GeneOntologyBiologicalProcess	negative regulation of natural killer cell mediated immunity	HLA-A HLA-F HLA-G IGF2	9.65e-05	41	121	4	GO:0002716
GeneOntologyBiologicalProcess	antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent	HLA-A HLA-F HLA-G	1.04e-04	16	121	3	GO:0002486
GeneOntologyBiologicalProcess	regulation of natural killer cell mediated immunity	HLA-A HLA-F LAG3 HLA-G IGF2	1.08e-04	80	121	5	GO:0002715
GeneOntologyBiologicalProcess	antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway	HLA-A HLA-F HLA-G	1.26e-04	17	121	3	GO:0002484
GeneOntologyBiologicalProcess	antigen processing and presentation of endogenous peptide antigen via MHC class Ib	HLA-A HLA-F HLA-G	1.26e-04	17	121	3	GO:0002476
GeneOntologyBiologicalProcess	antigen processing and presentation of peptide antigen via MHC class Ib	HLA-A HLA-F HLA-G	1.51e-04	18	121	3	GO:0002428
GeneOntologyBiologicalProcess	antigen processing and presentation of exogenous peptide antigen via MHC class I	HLA-A HLA-F HLA-G	1.51e-04	18	121	3	GO:0042590
GeneOntologyBiologicalProcess	negative regulation of leukocyte mediated cytotoxicity	HLA-A HLA-F HLA-G IGF2	1.65e-04	47	121	4	GO:0001911
GeneOntologyBiologicalProcess	neural tube development	CDK20 LIAS PTCH1 PLXNB2 CELSR1 GDF7 HECTD1	1.92e-04	202	121	7	GO:0021915
GeneOntologyBiologicalProcess	antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway	HLA-F HLA-G	2.03e-04	4	121	2	GO:0002488
GeneOntologyBiologicalProcess	antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway, TAP-dependent	HLA-F HLA-G	2.03e-04	4	121	2	GO:0002489
GeneOntologyBiologicalProcess	negative regulation of cell killing	HLA-A HLA-F HLA-G IGF2	2.45e-04	52	121	4	GO:0031342
GeneOntologyBiologicalProcess	antigen processing and presentation of endogenous peptide antigen via MHC class I	HLA-A HLA-F HLA-G	3.20e-04	23	121	3	GO:0019885
GeneOntologyBiologicalProcess	antigen processing and presentation of exogenous protein antigen via MHC class Ib, TAP-dependent	HLA-F HLA-G	3.37e-04	5	121	2	GO:0002481
GeneOntologyBiologicalProcess	antigen processing and presentation of exogenous peptide antigen via MHC class Ib	HLA-F HLA-G	3.37e-04	5	121	2	GO:0002477
GeneOntologyBiologicalProcess	antigen processing and presentation of endogenous peptide antigen	HLA-A HLA-F HLA-G	4.12e-04	25	121	3	GO:0002483
GeneOntologyBiologicalProcess	antigen processing and presentation via MHC class Ib	HLA-A HLA-F HLA-G	4.12e-04	25	121	3	GO:0002475
GeneOntologyCellularComponent	cis-Golgi network membrane	HLA-A HLA-F HLA-G VPS13B	3.10e-06	17	129	4	GO:0033106
GeneOntologyCellularComponent	MHC class Ib protein complex	HLA-A HLA-F HLA-G	7.89e-06	7	129	3	GO:0032398
GeneOntologyCellularComponent	MHC class I protein complex	HLA-A HLA-F HLA-G	2.67e-05	10	129	3	GO:0042612
GeneOntologyCellularComponent	MHC class I peptide loading complex	HLA-A HLA-F HLA-G	7.95e-05	14	129	3	GO:0042824
GeneOntologyCellularComponent	striated muscle myosin thick filament	MYOM1 OBSCN	2.25e-04	4	129	2	GO:0005863
GeneOntologyCellularComponent	Golgi medial cisterna	HLA-A HLA-F HLA-G	3.71e-04	23	129	3	GO:0005797
GeneOntologyCellularComponent	membrane raft	HLA-A HLA-F HLA-G TNFRSF10D PTCH1 HPSE PLD2 NOS1 HYAL2	4.20e-04	362	129	9	GO:0045121
GeneOntologyCellularComponent	membrane microdomain	HLA-A HLA-F HLA-G TNFRSF10D PTCH1 HPSE PLD2 NOS1 HYAL2	4.37e-04	364	129	9	GO:0098857
GeneOntologyCellularComponent	MHC protein complex	HLA-A HLA-F HLA-G	5.38e-04	26	129	3	GO:0042611
GeneOntologyCellularComponent	recycling endosome membrane	HLA-A HLA-F HLA-G SLC30A10 VPS13B	6.55e-04	112	129	5	GO:0055038
GeneOntologyCellularComponent	lumenal side of endoplasmic reticulum membrane	HLA-A HLA-F HLA-G	1.30e-03	35	129	3	GO:0098553
GeneOntologyCellularComponent	Cul4-RING E3 ubiquitin ligase complex	DCAF1 DCAF6 WDTC1	1.65e-03	38	129	3	GO:0080008
GeneOntologyCellularComponent	cis-Golgi network	HLA-A HLA-F HLA-G VPS13B	1.91e-03	85	129	4	GO:0005801
GeneOntologyCellularComponent	early endosome membrane	HLA-A HLA-F HLA-G SLC30A10 VPS13B EPHA8	2.05e-03	212	129	6	GO:0031901
GeneOntologyCellularComponent	sarcoplasmic reticulum	JPH4 XDH H6PD NOS1	2.16e-03	88	129	4	GO:0016529
GeneOntologyCellularComponent	endoplasmic reticulum exit site	HLA-A HLA-F HLA-G	2.21e-03	42	129	3	GO:0070971
MousePheno	spinal cord inflammation	HLA-A HLA-F HLA-G	1.94e-05	8	100	3	MP:0030987
Domain	EGF-like_CS	NID2 NTN3 CNTNAP1 MATN4 VWDE CELSR1 NCAN HYAL2 EPHA8	7.47e-05	261	127	9	IPR013032
Domain	EGF_2	NID2 NTN3 CNTNAP1 MATN4 VWDE CELSR1 NCAN HYAL2 EPHA8	8.40e-05	265	127	9	PS01186
Pathway	KEGG_MEDICUS_PATHOGEN_KSHV_MIR1_2_TO_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_I_MOLECULES	HLA-A HLA-F HLA-G	6.62e-06	6	99	3	M47468
Pathway	KEGG_MEDICUS_PATHOGEN_HTLV_1_P12_TO_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_I_MOLECULES	HLA-A HLA-F HLA-G	1.15e-05	7	99	3	M47582
Pathway	KEGG_MEDICUS_PATHOGEN_HPV_E5_TO_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_I_MOLECULES	HLA-A HLA-F HLA-G	1.15e-05	7	99	3	M47530
Pathway	REACTOME_ENDOSOMAL_VACUOLAR_PATHWAY	HLA-A HLA-F HLA-G	2.74e-05	9	99	3	MM14527
Pathway	REACTOME_ENDOSOMAL_VACUOLAR_PATHWAY	HLA-A HLA-F HLA-G	5.32e-05	11	99	3	M525
Pathway	KEGG_MEDICUS_REFERENCE_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_I_MOLECULES	HLA-A HLA-F HLA-G	7.06e-05	12	99	3	M47529
Pathway	REACTOME_ER_PHAGOSOME_PATHWAY	HLA-A HLA-F HLA-G	2.54e-04	18	99	3	MM14525
Pathway	BIOCARTA_CTL_PATHWAY	HLA-A HLA-F HLA-G	3.51e-04	20	99	3	MM1374
Pubmed	H-2Kb-restricted CTL epitopes from mouse heparanase elicit an antitumor immune response in vivo.	HLA-A HLA-F HLA-G HPSE	1.33e-08	8	131	4	18316618
Pubmed	Roles of lymphatic endothelial cells expressing peripheral tissue antigens in CD4 T-cell tolerance induction.	HLA-A HLA-F LAG3 HLA-G	6.22e-08	11	131	4	25857745
Pubmed	ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1.	IGSF8 TMEM67 TMEM201 HLA-A P3H3 HS6ST2 CNTNAP1 HLA-F SLC38A5 RNF213 MANEA H6PD PLXNB2 CELSR1 HS2ST1 SMPD1 HECTD1 DNASE1L1 PLXNB1	1.33e-07	1201	131	19	35696571
Pubmed	The immunoproteasomes are key to regulate myokines and MHC class I expression in idiopathic inflammatory myopathies.	HLA-A HLA-F HLA-G	5.19e-07	5	131	3	27522114
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	PITPNM2 RNF130 DCAF6 SCAF8 OBSCN RNF213 CEP192 H6PD HOXB6 TNRC18 IGF2 LDB1 HS2ST1 ARHGEF37 CSMD1 KAT6B HECTD1 CLEC16A VPS13B AGAP3	7.99e-07	1489	131	20	28611215
Pubmed	Distinct trafficking pathways mediate Nef-induced and clathrin-dependent major histocompatibility complex class I down-regulation.	HLA-A HLA-F HLA-G	1.04e-06	6	131	3	10982373
Pubmed	Effect of the V3 loop deletion of envelope glycoprotein on cellular responses and protection against challenge with recombinant vaccinia virus expressing gp160 of primary human immunodeficiency virus type 1 isolates.	HLA-A HLA-F HLA-G	1.04e-06	6	131	3	11932387
Pubmed	Molecular analysis of presentation by HLA-A2.1 of a promiscuously binding V3 loop peptide from the HIV-envelope protein to human cytotoxic T lymphocytes.	HLA-A HLA-F HLA-G	1.04e-06	6	131	3	8671651
Pubmed	The dileucine-based sorting motif in HIV-1 Nef is not required for down-regulation of class I MHC.	HLA-A HLA-F HLA-G	1.04e-06	6	131	3	10366557
Pubmed	The SH3 domain-binding surface and an acidic motif in HIV-1 Nef regulate trafficking of class I MHC complexes.	HLA-A HLA-F HLA-G	1.04e-06	6	131	3	9582271
Pubmed	Enhanced HIV infectivity and changes in GP120 conformation associated with viral incorporation of human leucocyte antigen class I molecules.	HLA-A HLA-F HLA-G	1.04e-06	6	131	3	10546855
Pubmed	Sequential cleavage by metallopeptidases and proteasomes is involved in processing HIV-1 ENV epitope for endogenous MHC class I antigen presentation.	HLA-A HLA-F HLA-G	1.04e-06	6	131	3	10799863
Pubmed	The cationic region from HIV tat enhances the cell-surface expression of epitope/MHC class I complexes.	HLA-A HLA-F HLA-G	1.04e-06	6	131	3	14595379
Pubmed	HIV immune evasion disruption of antigen presentation by the HIV Nef protein.	HLA-A HLA-F HLA-G	1.04e-06	6	131	3	21762823
Pubmed	The immunosuppressive peptide of HIV-1 gp41 like human type I interferons up-regulates MHC class I expression on H9 and U937 cells.	HLA-A HLA-F HLA-G	1.04e-06	6	131	3	9373217
Pubmed	Nef-mediated MHC class I down-regulation unmasks clonal differences in virus suppression by SIV-specific CD8(+) T cells independent of IFN-gamma and CD107a responses.	HLA-A HLA-F HLA-G	1.04e-06	6	131	3	19555986
Pubmed	Degenerate MHC restriction reveals the contribution of class I MHC molecules in determining the fine specificity of CTL recognition of an immunodominant determinant of HIV-1 gp160 V3 loop.	HLA-A HLA-F HLA-G	1.04e-06	6	131	3	9120272
Pubmed	On the role of the second coding exon of the HIV-1 Tat protein in virus replication and MHC class I downregulation.	HLA-A HLA-F HLA-G	1.04e-06	6	131	3	9840288
Pubmed	A single amino acid interchange yields reciprocal CTL specificities for HIV-1 gp160.	HLA-A HLA-F HLA-G	1.04e-06	6	131	3	2789433
Pubmed	Spatial and functional relationship of GGAs and AP-1 in Drosophila and HeLa cells.	HLA-A HLA-F HLA-G	1.04e-06	6	131	3	19847956
Pubmed	Repression of MHC class I gene promoter activity by two-exon Tat of HIV.	HLA-A HLA-F HLA-G	1.04e-06	6	131	3	8493575
Pubmed	Minor contribution of HLA class I-associated selective pressure to the variability of HIV-1 accessory protein Vpu.	HLA-A HLA-F HLA-G	1.04e-06	6	131	3	22503975
Pubmed	Three regions of HIV-1 gp160 contain clusters of immunodominant CTL epitopes.	HLA-A HLA-F HLA-G	1.04e-06	6	131	3	8877415
Pubmed	Endocytosis of major histocompatibility complex class I molecules is induced by the HIV-1 Nef protein.	HLA-A HLA-F HLA-G	1.04e-06	6	131	3	8612235
Pubmed	Generation of a functional cDNA encoding the LdH2 class-I molecule by using a single-LTR retroviral shuttle vector.	HLA-A HLA-F HLA-G	1.81e-06	7	131	3	1705528
Pubmed	Further studies on polymorphic expression of GM1 and GD1a in mouse liver. The presence of a third allele on the Ggm-1 locus.	HLA-A HLA-F HLA-G	1.81e-06	7	131	3	2808323
Pubmed	Nef interacts with the mu subunit of clathrin adaptor complexes and reveals a cryptic sorting signal in MHC I molecules.	HLA-A HLA-F HLA-G	1.81e-06	7	131	3	9586638
Pubmed	CD8+ T-cell expansion and maintenance after recombinant adenovirus immunization rely upon cooperation between hematopoietic and nonhematopoietic antigen-presenting cells.	HLA-A HLA-F HLA-G	1.81e-06	7	131	3	21088134
Pubmed	The Tla locus: a new allele and antigenic specificity.	HLA-A HLA-F HLA-G	1.81e-06	7	131	3	69663
Pubmed	Direct link between mhc polymorphism, T cell avidity, and diversity in immune defense.	HLA-A HLA-F HLA-G	1.81e-06	7	131	3	12459592
Pubmed	Multiple sequences related to classical histocompatibility antigens in the mouse genome.	HLA-A HLA-F HLA-G	1.81e-06	7	131	3	6264319
Pubmed	Sequence analysis of the C3H H-2K1k gene: relationship to the H-2 loci.	HLA-A HLA-F HLA-G	1.81e-06	7	131	3	2714856
Pubmed	Class I MHC molecules on hematopoietic cells can support intrathymic positive selection of T cell receptor transgenic T cells.	HLA-A HLA-F HLA-G	1.81e-06	7	131	3	10500200
Pubmed	Structural analysis of H-2Kf and H-2Kfm1 by using H-2K locus-specific sequences.	HLA-A HLA-F HLA-G	1.81e-06	7	131	3	2391419
Pubmed	Embryonic mouse STO cell-derived xenografts express hepatocytic functions in the livers of nonimmunosuppressed adult rats.	HLA-A HLA-F HLA-G	1.81e-06	7	131	3	15671142
Pubmed	GENETIC BASIS OF SUSCEPTIBILITY TO VIRAL LEUKAEMOGENESIS.	HLA-A HLA-F HLA-G	1.81e-06	7	131	3	14215561
Pubmed	A saturation hypothesis to explain both enhanced and impaired learning with enhanced plasticity.	HLA-A HLA-F HLA-G	1.81e-06	7	131	3	28234229
Pubmed	Interaction of H-2Db with mutant histocompatibility gene H (KH-11) in the mouse.	HLA-A HLA-F HLA-G	1.81e-06	7	131	3	6242891
Pubmed	Characterization of a severe parenchymal phenotype of experimental autoimmune encephalomyelitis in (C57BL6xB10.PL)F1 mice.	HLA-A HLA-F HLA-G	1.81e-06	7	131	3	17512611
Pubmed	Amino acid sequence of residues 1-98 of the K-2Kb murine major histocompatibility alloantigen: comparison with H-2Kb and H-2db reveals extensive localized differences.	HLA-A HLA-F HLA-G	1.81e-06	7	131	3	7018573
Pubmed	Induction of the H-2 D antigen during B cell activation.	HLA-A HLA-F HLA-G	1.81e-06	7	131	3	2642506
Pubmed	A complex major histocompatibility complex D locus variant generated by an unusual recombination mechanism in mice.	HLA-A HLA-F HLA-G	1.81e-06	7	131	3	9037062
Pubmed	Simultaneous assessment of CD4 and MHC-I downregulation by Nef primary isolates in the context of infection.	HLA-A HLA-F HLA-G	1.81e-06	7	131	3	19643141
Pubmed	Nucleic acid sequences of the H-2Ks and H-2Ksm1 genes.	HLA-A HLA-F HLA-G	1.81e-06	7	131	3	1840571
Pubmed	Natural killer cell tolerance persists despite significant reduction of self MHC class I on normal target cells in mice.	HLA-A HLA-F HLA-G	1.81e-06	7	131	3	20957233
Pubmed	Zooming in on the hydrophobic ridge of H-2D(b): implications for the conformational variability of bound peptides.	HLA-A HLA-F HLA-G	1.81e-06	7	131	3	11580250
Pubmed	V beta T cell repertoire of CD8+ splenocytes selected on nonpolymorphic MHC class I molecules.	HLA-A HLA-F HLA-G	1.81e-06	7	131	3	11086076
Pubmed	HLA-B*0702 transgenic, H-2KbDb double-knockout mice: phenotypical and functional characterization in response to influenza virus.	HLA-A HLA-F HLA-G	1.81e-06	7	131	3	12750360
Pubmed	Major histocompatibility complex (Mhc) class Ib gene duplications, organization and expression patterns in mouse strain C57BL/6.	HLA-A HLA-F HLA-G	1.81e-06	7	131	3	18416856
Pubmed	Convergent recombination shapes the clonotypic landscape of the naive T-cell repertoire.	HLA-A HLA-F HLA-G	1.81e-06	7	131	3	20974936
Pubmed	The role of peptides in T cell alloreactivity is determined by self-major histocompatibility complex molecules.	HLA-A HLA-F HLA-G	1.81e-06	7	131	3	10704462
Pubmed	West Nile virus T-cell ligand sequences shared with other flaviviruses: a multitude of variant sequences as potential altered peptide ligands.	HLA-A HLA-F HLA-G	1.81e-06	7	131	3	22573867
Pubmed	A novel H-2K splice form: predictions for other alternative H-2 splicing events.	HLA-A HLA-F HLA-G	1.81e-06	7	131	3	2908875
Pubmed	Comparison of exon 5 sequences from 35 class I genes of the BALB/c mouse.	HLA-A HLA-F HLA-G	1.81e-06	7	131	3	2584927
Pubmed	Transcripts of Tla genes.	HLA-A HLA-F HLA-G	1.81e-06	7	131	3	3496275
Pubmed	Comparative analysis of the CD8(+) T cell repertoires of H-2 class I wild-type/HLA-A2.1 and H-2 class I knockout/HLA-A2.1 transgenic mice.	HLA-A HLA-F HLA-G	1.81e-06	7	131	3	12147629
Pubmed	Mitotic recombination in germ cells generated two major histocompatibility complex mutant genes shown to be identical by RNA sequence analysis: Kbm9 and Kbm6.	HLA-A HLA-F HLA-G	1.81e-06	7	131	3	3458188
Pubmed	Direct binding of human immunodeficiency virus type 1 Nef to the major histocompatibility complex class I (MHC-I) cytoplasmic tail disrupts MHC-I trafficking.	HLA-A HLA-F HLA-G	1.81e-06	7	131	3	12414957
Pubmed	Antigens expressed by myelinating glia cells induce peripheral cross-tolerance of endogenous CD8+ T cells.	HLA-A HLA-F HLA-G	1.81e-06	7	131	3	19462379
Pubmed	Structural diversity of the classical H-2 genes: K, D, and L.	HLA-A HLA-F HLA-G	1.81e-06	7	131	3	1730883
Pubmed	DNA sequence analysis of the C3H H-2Kk and H-2Dk loci. Evolutionary relationships to H-2 genes from four other mouse strains.	HLA-A HLA-F HLA-G	1.81e-06	7	131	3	3680952
Pubmed	Thymus leukemia antigen controls intraepithelial lymphocyte function and inflammatory bowel disease.	HLA-A HLA-F HLA-G	1.81e-06	7	131	3	19004778
Pubmed	Comparison of the cloned H-2Kbm1 variant gene with the H-2Kb gene shows a cluster of seven nucleotide differences.	HLA-A HLA-F HLA-G	1.81e-06	7	131	3	6300887
Pubmed	H-2-linked regulation of xenotropic murine leukemia virus expression.	HLA-A HLA-F HLA-G	1.81e-06	7	131	3	6300850
Pubmed	The assembly of H2-Kb class I molecules translated in vitro requires oxidized glutathione and peptide.	HLA-A HLA-F HLA-G	1.81e-06	7	131	3	8500526
Pubmed	cDNA clone coding for part of a mouse H-2d major histocompatibility antigen.	HLA-A HLA-F HLA-G	1.81e-06	7	131	3	6265910
Pubmed	Cutting edge: MHC class I-Ly49 interaction regulates neuronal function.	HLA-A HLA-F HLA-G	1.81e-06	7	131	3	18453559
Pubmed	DNA polymorphisms defined by the Tu108 probe map to the Tla region of mouse chromosome 17.	HLA-A HLA-F HLA-G	1.81e-06	7	131	3	2906539
Pubmed	A single nucleotide difference at the 3' end of an intron causes differential splicing of two histocompatibility genes.	HLA-A HLA-F HLA-G	1.81e-06	7	131	3	3013627
Pubmed	CD4 and MHC class 1 down-modulation activities of nef alleles from brain- and lymphoid tissue-derived primary HIV-1 isolates.	HLA-A HLA-F HLA-G	1.81e-06	7	131	3	21165790
Pubmed	DNA sequence of the mouse H-2Dd transplantation antigen gene.	HLA-A HLA-F HLA-G	1.81e-06	7	131	3	3856254
Pubmed	Structure of a gene encoding a murine thymus leukemia antigen, and organization of Tla genes in the BALB/c mouse.	HLA-A HLA-F HLA-G	1.81e-06	7	131	3	3894562
Pubmed	Recognition of the Major Histocompatibility Complex (MHC) Class Ib Molecule H2-Q10 by the Natural Killer Cell Receptor Ly49C.	HLA-A HLA-F HLA-G	1.81e-06	7	131	3	27385590
Pubmed	Evolution of the mouse H-2K region: a hot spot of mutation associated with genes transcribed in embryos and/or germ cells.	HLA-A HLA-F HLA-G	1.81e-06	7	131	3	1348042
Pubmed	H2-K(b) and H2-D(b) regulate cerebellar long-term depression and limit motor learning.	HLA-A HLA-F HLA-G	1.81e-06	7	131	3	19346486
Pubmed	Liver sinusoidal endothelial cells veto CD8 T cell activation by antigen-presenting dendritic cells.	HLA-A HLA-F HLA-G	1.81e-06	7	131	3	18383043
Pubmed	Thymus-dependent memory phenotype CD8 T cells in naive B6.H-2Kb-/-Db-/- animals mediate an antigen-specific response against Listeria monocytogenes.	HLA-A HLA-F HLA-G	1.81e-06	7	131	3	16272298
Pubmed	Tissue-specific expression of an unusual H-2 (class I)-related gene.	HLA-A HLA-F HLA-G	1.81e-06	7	131	3	6956903
Pubmed	A physical map of the Q region of B1O.P.	HLA-A HLA-F HLA-G	1.81e-06	7	131	3	8833240
Pubmed	Transplantation tolerance to a single noninherited MHC class I maternal alloantigen studied in a TCR-transgenic mouse model.	HLA-A HLA-F HLA-G	1.81e-06	7	131	3	21178009
Pubmed	Expression and function of transplantation antigens with altered or deleted cytoplasmic domains.	HLA-A HLA-F HLA-G	1.81e-06	7	131	3	6604582
Pubmed	Isolation of a cDNA clone for the murine transplantation antigen H-2Kb.	HLA-A HLA-F HLA-G	1.81e-06	7	131	3	6954478
Pubmed	CD4 T cell help prevents CD8 T cell exhaustion and promotes control of Mycobacterium tuberculosis infection.	HLA-A HLA-F HLA-G	1.81e-06	7	131	3	34525366
Pubmed	The H-2Kkml mutation: a single nucleotide substitution is responsible for multiple functional differences in a class I MHC molecule.	HLA-A HLA-F HLA-G	1.81e-06	7	131	3	3374494
Pubmed	Extensive deletions in the Q region of the mouse major histocompatibility complex.	HLA-A HLA-F HLA-G	1.81e-06	7	131	3	3025084
Pubmed	DNA sequence of a class I pseudogene from the Tla region of the murine MHC: recombination at a B2 alu repetitive sequence.	HLA-A HLA-F HLA-G	1.81e-06	7	131	3	2543831
Pubmed	The class I major histocompatibility antigen gene activated in a line of SV40-transformed mouse cells is H-2Dd, not Qa/Tla.	HLA-A HLA-F HLA-G	1.81e-06	7	131	3	2989712
Pubmed	Unique biochemical properties of a mutant MHC class I molecule, H-2Ksm1.	HLA-A HLA-F HLA-G	1.81e-06	7	131	3	1280760
Pubmed	Three cDNA clones encoding mouse transplantation antigens: homology to immunoglobulin genes.	HLA-A HLA-F HLA-G	1.81e-06	7	131	3	6786753
Pubmed	Detection of a secreted form of the murine H-2 class I antigen with an antibody against its predicted carboxyl terminus.	HLA-A HLA-F HLA-G	1.81e-06	7	131	3	6583704
Pubmed	Expression of H-2Dd and H-2Ld mouse major histocompatibility antigen genes in L cells after DNA-mediated gene transfer.	HLA-A HLA-F HLA-G	1.81e-06	7	131	3	6571712
Pubmed	Mutation of a major histocompatibility class I locus, H-2D, leads to an increased virus burden and disease susceptibility in Theiler's virus-induced demyelinating disease.	HLA-A HLA-F HLA-G	1.81e-06	7	131	3	9222352
Pubmed	Probing for membrane domains in the endoplasmic reticulum: retention and degradation of unassembled MHC class I molecules.	HLA-A HLA-F HLA-G	1.81e-06	7	131	3	12006653
Pubmed	Changes in the coding sequence of the H-2Dk gene of metastatic cells that might account for immunogenic abnormality of its encoded antigen.	HLA-A HLA-F HLA-G	1.81e-06	7	131	3	1699529
Pubmed	Distinctive interactions at multiple site 2 subsites by allele-specific rat and mouse ly49 determine functional binding and class I MHC specificity.	HLA-A HLA-F HLA-G	1.81e-06	7	131	3	17982076
Pubmed	Identification of an H-2 Kb-presented Moloney murine leukemia virus cytotoxic T-lymphocyte epitope that displays enhanced recognition in H-2 Db mutant bm13 mice.	HLA-A HLA-F HLA-G	1.81e-06	7	131	3	7520098
Pubmed	Cooperative binding of the class I major histocompatibility complex cytoplasmic domain and human immunodeficiency virus type 1 Nef to the endosomal AP-1 complex via its mu subunit.	HLA-A HLA-F HLA-G	1.81e-06	7	131	3	18057255
Pubmed	Crystal structures of murine MHC Class I H-2 D(b) and K(b) molecules in complex with CTL epitopes from influenza A virus: implications for TCR repertoire selection and immunodominance.	HLA-A HLA-F HLA-G	1.81e-06	7	131	3	15644207
Pubmed	How a single T cell receptor recognizes both self and foreign MHC.	HLA-A HLA-F HLA-G	1.81e-06	7	131	3	17418792
Pubmed	PCR identification of class I major histocompatibility complex genes transcribed in mouse blastocyst and placenta.	HLA-A HLA-F HLA-G	1.81e-06	7	131	3	9185075
Interaction	SDF2L1 interactions	TMEM67 RNF130 P3H3 HS6ST2 CNTNAP1 HLA-F H6PD PLXNB2 VWDE CELSR1 HS2ST1 HYAL2 WDTC1	1.07e-07	322	125	13	int:SDF2L1
Interaction	HLA-G interactions	TMEM67 HLA-A HS6ST2 HLA-F HLA-G PLXNB2 HS2ST1 HYAL2	7.23e-07	118	125	8	int:HLA-G
Interaction	SEMA4G interactions	HLA-G TNFRSF10D PTCH1 PLXNB2 DNASE1L1 PLXNB1	9.13e-07	53	125	6	int:SEMA4G
Interaction	BTNL2 interactions	TMEM67 HLA-A HS6ST2 CNTNAP1 HLA-F PLXNB2 CELSR1 HYAL2	5.62e-06	155	125	8	int:BTNL2
Interaction	HS2ST1 interactions	DCAF6 HLA-A HLA-G RNF213 P2RY2 HS2ST1 HECTD1	8.41e-06	117	125	7	int:HS2ST1
Interaction	CFC1 interactions	TMEM67 P3H3 CNTNAP1 HLA-F VWDE CELSR1 HYAL2	1.37e-05	126	125	7	int:CFC1
Interaction	ST8SIA4 interactions	TMEM67 HLA-F PTCH1 PLXNB2 DNASE1L1 HYAL2	1.38e-05	84	125	6	int:ST8SIA4
Interaction	GGH interactions	P3H3 HS6ST2 SHMT2 H6PD PLXNB2 HPSE CELSR1 HYAL2 PLXNB1	2.11e-05	243	125	9	int:GGH
Interaction	LILRB1 interactions	HLA-A HLA-F HLA-G	2.71e-05	10	125	3	int:LILRB1
Interaction	LILRB2 interactions	HLA-A HLA-F HLA-G	2.71e-05	10	125	3	int:LILRB2
Interaction	MANEA interactions	TRHDE NID2 MANEA ARSF LRP3	3.52e-05	60	125	5	int:MANEA
Interaction	SFTPC interactions	TMEM67 HLA-A HS6ST2 CNTNAP1 HLA-F PLXNB2 CELSR1 HYAL2	7.45e-05	222	125	8	int:SFTPC
Interaction	C1orf54 interactions	P3H3 HS6ST2 CNTNAP1 PLXNB2 HPSE CELSR1 HYAL2	8.31e-05	167	125	7	int:C1orf54
Interaction	CRLF1 interactions	HLA-F SHMT2 PTCH1 DNASE1L1 WDTC1	1.03e-04	75	125	5	int:CRLF1
Interaction	LLCFC1 interactions	NID2 CNTNAP1 PLXNB2 VWDE SMPD1 HYAL2	1.08e-04	121	125	6	int:LLCFC1
Interaction	CD1B interactions	TMEM67 RNF130 HLA-A HS6ST2 HLA-F	1.17e-04	77	125	5	int:CD1B
GeneFamily	Cyclin dependent kinases	CDK20 CDK11A CDK2 CDK3	8.25e-06	26	91	4	496
GeneFamily	WD repeat domain containing\|DDB1 and CUL4 associated factors	DCAF1 DCAF6 WDTC1	9.53e-05	18	91	3	498
GeneFamily	Adenosine deaminases acting on RNA	ADAT3 ADARB2	6.88e-04	8	91	2	1303
GeneFamily	Plexins	PLXNB2 PLXNB1	8.82e-04	9	91	2	683
GeneFamily	C1-set domain containing	HLA-A HLA-F HLA-G	1.23e-03	42	91	3	591
GeneFamily	Histocompatibility complex\|C1-set domain containing	HLA-A HLA-F HLA-G	1.41e-03	44	91	3	588
Coexpression	TABULA_MURIS_SENIS_BLADDER_LEUKOCYTE_AGEING	HLA-A HLA-F LAG3 HLA-G	2.40e-06	20	127	4	MM3682
Coexpression	MIKKELSEN_ES_ICP_WITH_H3K4ME3_AND_H3K27ME3	HLA-A CNTNAP1 HLA-F HLA-G PIWIL2 ADARB2 NCAN	7.37e-06	146	127	7	MM856
Coexpression	NABA_MATRISOME	NID2 P3H3 NTF4 NTN3 MATN4 ADAMTS13 ADAMTS5 VWA7 PLXNB2 HPSE VWDE IGF2 GDF7 NCAN HYAL2 PLXNB1	3.04e-05	1008	127	16	MM17056
Coexpression	NABA_MATRISOME	NID2 P3H3 NTF4 NTN3 MATN4 ADAMTS13 ADAMTS5 VWA7 PLXNB2 HPSE VWDE IGF2 GDF7 NCAN HYAL2 PLXNB1	3.76e-05	1026	127	16	M5889
Coexpression	GSE22611_NOD2_TRANSD_VS_CTRL_TRANSD_HEK293_MDP_STIM_6H_DN	SHMT2 PLXNB2 CELSR1 SLAMF7 HYAL2 OPLAH WDTC1	4.77e-05	195	127	7	M8160
Coexpression	GSE26488_CTRL_VS_PEPTIDE_INJECTION_HDAC7_DELTAP_TG_OT2_THYMOCYTE_DN	NID2 MATN4 ATG2A RGS3 MBD3 HYAL2 AGAP3	5.59e-05	200	127	7	M8199
Coexpression	GSE45739_UNSTIM_VS_ACD3_ACD28_STIM_WT_CD4_TCELL_DN	PRR5L LAG3 ATG2A PTCH1 RGS3 FCGBP SLAMF7	5.59e-05	200	127	7	M9887
Coexpression	GSE16522_MEMORY_VS_NAIVE_ANTI_CD3CD28_STIM_CD8_TCELL_DN	DCAF1 LAG3 HLA-G SHMT2 XDH RNF213 CDK2	5.59e-05	200	127	7	M3662
Coexpression	GSE20366_TREG_VS_NAIVE_CD4_TCELL_DEC205_CONVERSION_DN	CDK20 KRT7 PRR5L CNTNAP1 USP43 FAM83E OPLAH	5.59e-05	200	127	7	M4334
Coexpression	MEISSNER_BRAIN_HCP_WITH_H3K27ME3	DMGDH KRT7 NTF4 HOXB6 CELSR1 IGF2 GDF7 GRIN3B	5.61e-05	272	127	8	M1938
Coexpression	TABULA_MURIS_SENIS_LUNG_ENDOTHELIAL_CELL_OF_LYMPHATIC_VESSEL_AGEING	HLA-A HLA-F HLA-G	5.94e-05	16	127	3	MM3766
Coexpression	MEISSNER_BRAIN_HCP_WITH_H3K27ME3	DMGDH KRT7 NTF4 HOXB6 CELSR1 IGF2 GDF7 GRIN3B	7.22e-05	282	127	8	MM822
Coexpression	JIANG_MELANOMA_TRM10_LAMINA_PROPRIA	HLA-A HLA-F LAG3 PTPRCAP SLAMF7	8.22e-05	91	127	5	M48974
Coexpression	GAUTAM_EYE_IRIS_CILIARY_BODY_PUTATIVE_STEM_CELLS	PITPNM2 RNF130 NUDT14 SRSF1 PLXNB2 ABI2 TLN2 PLXNB1	9.19e-05	292	127	8	M43600
Coexpression	WUNDER_INFLAMMATORY_RESPONSE_AND_CHOLESTEROL_DN	HLA-A HLA-F HLA-G	1.02e-04	19	127	3	MM797
Coexpression	MIKKELSEN_NPC_ICP_WITH_H3K27ME3	HLA-A HLA-F HLA-G	1.02e-04	19	127	3	MM862
Coexpression	SENGUPTA_EBNA1_ANTICORRELATED	HLA-A HLA-F CAMTA2 H6PD USP35 WDTC1	1.37e-04	161	127	6	M18742
Coexpression	RUAN_RESPONSE_TO_TNF_UP	HLA-A HLA-F HLA-G	1.39e-04	21	127	3	MM651
Coexpression	LEE_BMP2_TARGETS_UP	RNF130 KRT7 HLA-A HLA-F HLA-G H6PD PLXNB2 RGS3 TMCC3 HOXB6 PDLIM2 VPS13B OPLAH	1.49e-04	805	127	13	MM1067
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_UP	HLA-A HLA-F HLA-G SHMT2 TNFRSF10D SMPD1 HYAL2 CDK2	1.65e-04	318	127	8	M11171
Coexpression	TABULA_MURIS_SENIS_HEART_AND_AORTA_SMOOTH_MUSCLE_CELL_AGEING	HLA-A HLA-F HLA-G C11orf96	1.70e-04	57	127	4	MM3716
ToppCell	COVID-19_Severe-CD8+_Tem\|COVID-19_Severe / Disease condition and Cell class	PRR5L HLA-A LAG3 RNF213 ATG2A PTCH1 TMCC3 PTPRCAP RASSF1 SLAMF7	3.66e-10	195	132	10	ff7ae62393e1c858a10592db8e6d9f36b8bae396
ToppCell	PBMC-Severe-Lymphocyte-T/NK-CD8+_T-CD8+_Tem\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	PRR5L HLA-A HLA-F LAG3 RNF213 ATG2A PTCH1 PTPRCAP RASSF1 SLAMF7	4.04e-10	197	132	10	2b3a56bb1d40bc1284a5931c4e7b373660de5402
ToppCell	COVID-19_Severe-Lymphoid_T/NK-CD8+_Tem\|COVID-19_Severe / Disease group, lineage and cell class	PRR5L HLA-A HLA-F LAG3 RNF213 ATG2A PTCH1 PTPRCAP RASSF1 SLAMF7	4.04e-10	197	132	10	f0bac4d5c3160933ac3786cec8dadffb35d711ea
ToppCell	PBMC-Severe-Lymphocyte-T/NK-CD8+_T-CD8+_Tem-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	PRR5L HLA-A HLA-F LAG3 RNF213 ATG2A PTCH1 PTPRCAP RASSF1 SLAMF7	4.04e-10	197	132	10	f73ece3aca28c0db5db0f12e026d42c6c36b9efb
ToppCell	PBMC-Severe-Lymphocyte-T/NK-CD8+_T-CD8+_Tem\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	PRR5L HLA-A HLA-F LAG3 RNF213 ATG2A PTCH1 PTPRCAP RASSF1 SLAMF7	4.04e-10	197	132	10	e70e7d97823a762def3970d94a0e897981a6c922
ToppCell	PBMC-Severe-Lymphocyte-T/NK-CD8+_T-CD8+_Tem-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	PRR5L HLA-A HLA-F LAG3 RNF213 ATG2A PTCH1 PTPRCAP RASSF1 SLAMF7	4.04e-10	197	132	10	bce0135a96910d2bace62a3408a1a6fdac0cf0df
ToppCell	COVID-19-COVID-19_Severe-Lymphocyte-T/NK-CD8+_Tem\|COVID-19_Severe / Disease, condition lineage and cell class	PRR5L HLA-A HLA-F LAG3 RNF213 ATG2A PTCH1 PTPRCAP RASSF1 SLAMF7	4.69e-10	200	132	10	31859b8db7ea17e48b7b54e92f0d76aeb755e7ca
ToppCell	COVID-19-COVID-19_Severe-Lymphocyte-T/NK-gd_T\|COVID-19_Severe / Disease, condition lineage and cell class	PRR5L HLA-A HLA-F LAG3 RNF213 PTCH1 FCGBP PTPRCAP RASSF1 SLAMF7	4.69e-10	200	132	10	f72bc3f6606ae77fe1b0a972e35b3ce0727804d9
ToppCell	PBMC-Severe-Lymphocyte-T/NK-CD8+_T\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	PRR5L HLA-A HLA-F LAG3 RNF213 PTCH1 PTPRCAP RASSF1 SLAMF7	7.51e-09	196	132	9	0f3c7fd450aaa1f866b8558692534c0ea2a34e75
ToppCell	PBMC-Severe-Lymphocyte-T/NK-CD8+_T\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	PRR5L HLA-A HLA-F LAG3 RNF213 PTCH1 PTPRCAP RASSF1 SLAMF7	7.51e-09	196	132	9	4e1f8828413896ab8a4ec92a89d6789e8e37e05a
ToppCell	3'_v3-blood-Lymphocytic_T_CD8-Tem/emra_CD8\|blood / Manually curated celltypes from each tissue	PRR5L HLA-A HLA-F LAG3 RNF213 RASSF1 SLAMF7 PDLIM2	1.03e-07	190	132	8	5624f711b34132081f93fa70702316962e3e3c64
ToppCell	normal-na-Lymphocytic_T-CytoT_GZMH+-female\|normal / PBMC cell types (v2) per disease, treatment status, and sex	PRR5L HLA-A LAG3 RNF213 ATG2A PTPRCAP RASSF1 SLAMF7	1.16e-07	193	132	8	3184a5f454e3ac5a81f6bacf9bd8f07d9d448fba
ToppCell	normal-na-Lymphocytic_T-CytoT_GZMH+\|normal / PBMC cell types (v2) per disease, treatment status, and sex	PRR5L HLA-A LAG3 RNF213 ATG2A PTPRCAP RASSF1 SLAMF7	1.16e-07	193	132	8	123d4d13c8944c32bf4a5d7fdc65e3b65aa568ef
ToppCell	COVID-19_Severe-Lymphoid_T/NK-gd_T\|COVID-19_Severe / Disease group, lineage and cell class	PRR5L HLA-A LAG3 RNF213 PTCH1 PTPRCAP RASSF1 SLAMF7	1.25e-07	195	132	8	9990440bda7fac5d00ef80444fab07459be625e1
ToppCell	PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	PRR5L HLA-A LAG3 RNF213 PTCH1 PTPRCAP RASSF1 SLAMF7	1.30e-07	196	132	8	418e8e0a51c5cb60e3b903e7d2d800dc8b9f3d5c
ToppCell	PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	PRR5L HLA-A LAG3 RNF213 PTCH1 PTPRCAP RASSF1 SLAMF7	1.30e-07	196	132	8	581fc8c8d42005aacd7b401a2c9d1fc331fb4af7
ToppCell	PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	PRR5L HLA-A LAG3 RNF213 PTCH1 PTPRCAP RASSF1 SLAMF7	1.30e-07	196	132	8	6beaf0c2799424c59819b286fbb5c1a83d85e4d1
ToppCell	PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	PRR5L HLA-A LAG3 RNF213 PTCH1 PTPRCAP RASSF1 SLAMF7	1.30e-07	196	132	8	c35f2349dfe35baa845f790b9f31673dceac54c0
ToppCell	severe-CD8+_Tem\|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	PRR5L HLA-A HLA-F LAG3 RNF213 ATG2A RASSF1 SLAMF7	1.52e-07	200	132	8	aaa2cd326dc15dee2fd975ca133359c5826f6a75
ToppCell	wk_20-22-Epithelial-Proximal_epithelial-SMG_basal_1\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	KRT7 ADAMTS13 TRIM29 VWDE FCGBP TRIM17 ARHGEF37	4.70e-07	158	132	7	adad97e6cf479d42791c5ba9cbc5f15f469322bf
ToppCell	systemic_lupus_erythematosus-flare-Lymphocytic_NK-NK_bright-female\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	HS6ST2 RNF213 SIX4 TRIM29 RGS3 PTPRCAP SLAMF7	1.17e-06	181	132	7	9c4f9abb9335da2b07644bca8faff1baa1bb9f5b
ToppCell	COVID-19_Mild-gd_T\|COVID-19_Mild / Disease condition and Cell class	HLA-A LAG3 HLA-G RNF213 PTCH1 PTPRCAP SLAMF7	1.26e-06	183	132	7	f593a89b0aa8fffdfa403769916facfd30358521
ToppCell	COVID-19_Severe-gd_T\|COVID-19_Severe / Disease condition and Cell class	HLA-A DNAH10 LAG3 RNF213 PTCH1 PTPRCAP SLAMF7	1.31e-06	184	132	7	791f1bcb954aadc63d4117c400537d036f68734d
ToppCell	facs-Lung-18m-Epithelial-airway_epithelial-respiratory_basal_cell\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	KRT7 NTF4 HS6ST2 SIX4 TRIM29 CELSR1 PLXNB1	1.62e-06	190	132	7	47e07ea22733306d8885ee9e5f0b033e2f5e2afb
ToppCell	facs-Lung-18m-Epithelial-airway_epithelial-respiratory_basal_cell-basal_epithelial_cell_of_bronchioalveolar_tree\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	KRT7 NTF4 HS6ST2 SIX4 TRIM29 CELSR1 PLXNB1	1.62e-06	190	132	7	261b8afddfdcba4f70b50df126cef7ad00a0aae0
ToppCell	systemic_lupus_erythematosus-managed-Lymphocytic_T-CytoT_GZMH+\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	PRR5L HLA-A LAG3 ATG2A PTPRCAP RASSF1 SLAMF7	1.74e-06	192	132	7	01d01c9293f2439dc4c34c648273319c9beee5c7
ToppCell	systemic_lupus_erythematosus-managed-Lymphocytic_T-CytoT_GZMH+-female\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	PRR5L HLA-A LAG3 ATG2A PTPRCAP RASSF1 SLAMF7	1.74e-06	192	132	7	0f8c63de26128694f4522f9f6d029e4628c890bc
ToppCell	PBMC-Control-Lymphocyte-T/NK-CD8+_T-CD8+_Tem\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	PRR5L HLA-A LAG3 RNF213 PTPRCAP RASSF1 SLAMF7	1.86e-06	194	132	7	e72be6dc2711c1d4f16943c8615cf9dc2e961ff3
ToppCell	PBMC-Control-Lymphocyte-T/NK-CD8+_T-CD8+_Tem\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	PRR5L HLA-A LAG3 RNF213 PTPRCAP RASSF1 SLAMF7	1.86e-06	194	132	7	ac03be73fdc32dacd4a450c0fb28617e043b8444
ToppCell	PBMC-Control-Lymphocyte-T/NK-CD8+_T-CD8+_Tem-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	PRR5L HLA-A LAG3 RNF213 PTPRCAP RASSF1 SLAMF7	1.86e-06	194	132	7	7ab4418a8a12c488d74af3676bdac672628da80c
ToppCell	PBMC-Control-Lymphocyte-T/NK-CD8+_T-CD8+_Tem-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	PRR5L HLA-A LAG3 RNF213 PTPRCAP RASSF1 SLAMF7	1.86e-06	194	132	7	760761ce7d22edf9a8cec71e8ab0caa273fce3f7
ToppCell	Multiple_Sclerosis-Lymphocyte-T_NK-CD8_TEM\|Multiple_Sclerosis / Disease, Lineage and Cell Type	PRR5L HLA-A HLA-F LAG3 RNF213 RASSF1 SLAMF7	1.86e-06	194	132	7	fa53f1aab2f5923e90f090e10e3560b583441dc4
ToppCell	Control-CD8+_Tem\|Control / Disease condition and Cell class	HLA-A LAG3 RNF213 ATG2A PTPRCAP RASSF1 SLAMF7	1.92e-06	195	132	7	7503b3e032f95b350a2782d28e4d412a8dc9ebcc
ToppCell	severe-CD8+_Tem\|severe / disease stage, cell group and cell class	HLA-A HLA-F LAG3 RNF213 ATG2A RASSF1 PDLIM2	1.99e-06	196	132	7	9456a5879948e25bc483a7233c274da841ef2c68
ToppCell	390C-Lymphocytic-NK_cells-NK_cell_D\|NK_cells / Donor, Lineage, Cell class and subclass (all cells)	DMGDH PIWIL2 CELSR1 PTPRCAP KCNA7 NCAN	2.00e-06	125	132	6	9e98dcfdc768ae492f453efc08926164bbb0a909
ToppCell	COVID_non-vent-Lymphocytic-T_cell-CD8+_Memory_T_cell\|COVID_non-vent / Disease condition, Lineage, Cell class and subclass	PRR5L HLA-A LAG3 RNF213 PTCH1 PTPRCAP SLAMF7	2.06e-06	197	132	7	836061acd7f0d5de89b16f52ec679bdf09eac9db
ToppCell	systemic_lupus_erythematosus-treated-Lymphocytic_NK-NK_dim\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	PRR5L HLA-A RNF213 ST6GALNAC6 RGS3 PTPRCAP SLAMF7	2.06e-06	197	132	7	4e141dfb094e10383d815fc7108b11a0584c3a4b
ToppCell	systemic_lupus_erythematosus-treated-Lymphocytic_NK-NK_dim-female\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	PRR5L HLA-A RNF213 ST6GALNAC6 RGS3 PTPRCAP SLAMF7	2.06e-06	197	132	7	08286770c0b707a7a4436ea8d4416ddfbfe2dc0c
ToppCell	COVID_vent-Lymphocytic-T_cell-CD8+_Memory_T_cell\|COVID_vent / Disease condition, Lineage, Cell class and subclass	PRR5L LAG3 RNF213 PTCH1 PTPRCAP RASSF1 SLAMF7	2.06e-06	197	132	7	d4dfb3b561d0783cdbee4e8d27009ad81df695cb
ToppCell	PBMC-Mild-Lymphocyte-T/NK-Other_T-gd_T-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	HLA-A LAG3 RNF213 ATG2A PTCH1 PTPRCAP SLAMF7	2.13e-06	198	132	7	a1b310274aa9b3d2aa1fe9488d67422bf4ac81d2
ToppCell	healthy_donor-Lymphocytic-ILC-NK_cell\|healthy_donor / Disease condition, Lineage, Cell class and subclass	PRR5L HLA-A RNF213 RGS3 PTPRCAP RASSF1 SLAMF7	2.13e-06	198	132	7	d7053a898e04478c577381085f615edaad3cdc5b
ToppCell	PBMC-Mild-Lymphocyte-T/NK-Other_T-gd_T\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	HLA-A LAG3 RNF213 ATG2A PTCH1 PTPRCAP SLAMF7	2.13e-06	198	132	7	76aff381403bc5a8a9cc73eb1e5dbdc0bac7de6c
ToppCell	PBMC-Mild-Lymphocyte-T/NK-Other_T-gd_T\|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)	HLA-A LAG3 RNF213 ATG2A PTCH1 PTPRCAP SLAMF7	2.13e-06	198	132	7	a781fd35a7cda8b7760c2e3ddccaac7aac26c979
ToppCell	healthy_donor-Lymphocytic-ILC\|healthy_donor / Disease condition, Lineage, Cell class and subclass	PRR5L HLA-A RNF213 RGS3 PTPRCAP RASSF1 SLAMF7	2.13e-06	198	132	7	aa33be29e26f1b8facfc894413099083ae3bbb1b
ToppCell	PBMC-Mild-Lymphocyte-T/NK-Other_T-gd_T-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	HLA-A LAG3 RNF213 ATG2A PTCH1 PTPRCAP SLAMF7	2.13e-06	198	132	7	df399674345c45738d765a8354ea8d1484572c34
ToppCell	COVID-19_Mild-Lymphoid_T/NK-gd_T\|COVID-19_Mild / Disease group, lineage and cell class	HLA-A LAG3 RNF213 ATG2A PTCH1 PTPRCAP SLAMF7	2.13e-06	198	132	7	6aea5d00c417708f05b6d2dfe5a962d80864f8eb
ToppCell	PBMC-Control-Lymphocyte-T/NK-NK_cell-NK\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	PRR5L HLA-A RNF213 RGS3 PTPRCAP RASSF1 SLAMF7	2.20e-06	199	132	7	4820f5bcd7bc34c2ebf6a3422cc8eb383a3b5a4e
ToppCell	PBMC-Control-Lymphocyte-T/NK-NK_cell\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	PRR5L HLA-A RNF213 RGS3 PTPRCAP RASSF1 SLAMF7	2.20e-06	199	132	7	eb05ccae5187e4701bbbe6d714a6d2808fbcf306
ToppCell	PBMC-Control-Lymphocyte-T/NK-NK_cell\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	PRR5L HLA-A RNF213 RGS3 PTPRCAP RASSF1 SLAMF7	2.20e-06	199	132	7	10c8729b779073c3bf808e85958d59147f0be5c5
ToppCell	PBMC-Control-Lymphocyte-T/NK-NK_cell-NK-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	PRR5L HLA-A RNF213 RGS3 PTPRCAP RASSF1 SLAMF7	2.20e-06	199	132	7	867fd292f3879982422e840e087bfdb3b21a8715
ToppCell	PBMC-Control-Lymphocyte-T/NK-NK_cell-NK-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	PRR5L HLA-A RNF213 RGS3 PTPRCAP RASSF1 SLAMF7	2.20e-06	199	132	7	5e9fe852a70546c9d235414a2c26ca3e67ba6eb9
ToppCell	Control-Lymphoid_T/NK-NK\|Control / Disease group, lineage and cell class	PRR5L HLA-A RNF213 RGS3 PTPRCAP RASSF1 SLAMF7	2.20e-06	199	132	7	94b2693a8378b9b2c58c6aebb2c6658d75b2e3de
ToppCell	severe-gd_T\|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	HLA-A HLA-F LAG3 RNF213 ATG2A RASSF1 SLAMF7	2.20e-06	199	132	7	e5a17a9f8f3be05d6abe1116607d17633df3c7ef
ToppCell	PBMC-Control-Lymphocyte-T/NK-NK_cell-NK\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	PRR5L HLA-A RNF213 RGS3 PTPRCAP RASSF1 SLAMF7	2.20e-06	199	132	7	d2c9fb69e5ef75778a1652da293fcf8cfa7ecfcc
ToppCell	COVID-19-COVID-19_Mild-Lymphocyte-T/NK-gd_T\|COVID-19_Mild / Disease, condition lineage and cell class	HLA-A LAG3 RNF213 ATG2A PTCH1 PTPRCAP SLAMF7	2.28e-06	200	132	7	6560753d3df2f87860b52052d4881aa45410f666
ToppCell	Control-Control-Lymphocyte-T/NK-CD8+_Tem\|Control / Disease, condition lineage and cell class	PRR5L HLA-A LAG3 RNF213 PTPRCAP RASSF1 SLAMF7	2.28e-06	200	132	7	fddb3df5b90eb97ef8ed80fac320c1a90903f012
ToppCell	severe-gd_T\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	HLA-F LAG3 RNF213 ATG2A RASSF1 SLAMF7 EPHA8	2.28e-06	200	132	7	2253d74049cc49c92e897ff4aa298d913daeb739
ToppCell	Control-Control-Lymphocyte-T/NK-NK\|Control / Disease, condition lineage and cell class	PRR5L HLA-A RNF213 RGS3 PTPRCAP RASSF1 SLAMF7	2.28e-06	200	132	7	c64c27dbf4df42ca2ad2bd94b50fab87b4050ef3
ToppCell	COVID-19-COVID-19_Mild-Lymphocyte-T/NK-NK_activated\|COVID-19_Mild / Disease, condition lineage and cell class	PRR5L HLA-G RNF213 PTCH1 RGS3 PTPRCAP SLAMF7	2.28e-06	200	132	7	2281debd86e5d92e8fe0397aec9ef670800f7471
ToppCell	MS-Multiple_Sclerosis-Lymphocyte-T/NK-CD8+_Tem\|Multiple_Sclerosis / Disease, condition lineage and cell class	PRR5L HLA-A HLA-F LAG3 RNF213 RASSF1 SLAMF7	2.28e-06	200	132	7	cba63f8f2e7530e5539f7f5d93b3bcf5d693f6b9
ToppCell	Mild/Remission-B_intermediate-14\|World / disease group and sub_cluster of B and Plasma cells(res = 0.5)	DNAH10 PLXNB2 KCNA7 C11orf96 USP35 OPLAH	3.00e-06	134	132	6	5bd1e3fa6278facd9e949e9e5e244e700190126b
ToppCell	Mild/Remission-B_intermediate-14\|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5)	DNAH10 PLXNB2 KCNA7 C11orf96 USP35 OPLAH	4.03e-06	141	132	6	69e32125a0e8f0c8561e5e7a93607f368f09546f
ToppCell	TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-5\|TCGA-Ovary / Sample_Type by Project: Shred V9	DCAF1 DCAF6 OBSCN VWA7 PLXNB1 WDTC1	1.03e-05	166	132	6	32d2eaf8a5d03881bf74d680825af2d5110b082d
ToppCell	PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ILDR2 NID2 KRT7 JPH4 ADAMTS5 IGF2	1.06e-05	167	132	6	7abc785e688a384672d7fb5a62d32538fe7e5a51
ToppCell	PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ILDR2 NID2 KRT7 JPH4 ADAMTS5 IGF2	1.06e-05	167	132	6	d50311b1f66f143bae4c4cf50e2e9b13c85d6920
ToppCell	facs-Limb_Muscle-Muscle_forelimb_and_hindlimb-18m-Lymphocytic-B_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	JPH4 SLC38A5 LACTBL1 SLC7A4 PTPRCAP GRIN3B	1.18e-05	170	132	6	4ab2a890c8631028ee9099d2faf6091c742a317b
ToppCell	3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	TMEM67 DNAH10 CNTNAP1 USP43 LRRC53 GRIN3B	1.63e-05	180	132	6	92fb01b91261b3103454924cde56add337b41844
ToppCell	3'_v3-lymph-node_spleen-Lymphocytic_T_CD8-Trm/em_CD8\|lymph-node_spleen / Manually curated celltypes from each tissue	PRR5L HLA-A HLA-F LAG3 RNF213 SLAMF7	1.73e-05	182	132	6	f857b32de19240a8aca1685f7a78b4e53b04875c
ToppCell	normal-na-Lymphocytic_T-CytoT_GZMK+-male\|normal / PBMC cell types (v2) per disease, treatment status, and sex	HLA-A LAG3 RNF213 ATG2A PTPRCAP EPHA8	1.79e-05	183	132	6	79defd22b3194dad16db55b9bdd220c09c1e6b90
ToppCell	normal-na-Lymphocytic_T-CytoT_GZMH+-male\|normal / PBMC cell types (v2) per disease, treatment status, and sex	HLA-A HLA-F LAG3 RNF213 ATG2A PTPRCAP	1.90e-05	185	132	6	097d628f92e13250c15b550f2fd1f4225fc07558
ToppCell	facs-Lung-EPCAM-18m-Epithelial-Basal\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KRT7 NTF4 HS6ST2 SIX4 TRIM29 PLXNB1	2.14e-05	189	132	6	783c1db856f2defe6f3b8748dd0bc29a8102f6d1
ToppCell	facs-Trachea-24m-Epithelial-airway_epithelial-respiratory_basal_cell-basal_epithelial_cell_of_trachea\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	KRT7 FAM83E TRIM29 CELSR1 FCGBP PLXNB1	2.14e-05	189	132	6	ee15b4fb3a1cfda80bcf210a23f04f242594015e
ToppCell	facs-Trachea-24m-Epithelial-airway_epithelial-respiratory_basal_cell\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	KRT7 FAM83E TRIM29 CELSR1 FCGBP PLXNB1	2.14e-05	189	132	6	dc6f6fae84347d145bea71b49eaeeb3028e9c4ae
ToppCell	facs-Lung-EPCAM-18m-Epithelial-respiratory_basal_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KRT7 NTF4 HS6ST2 SIX4 TRIM29 PLXNB1	2.14e-05	189	132	6	88b72fafbe58463543e0818f27f3dd9e5b4d34d2
ToppCell	(2)_Fibroblasts-(21)_Fibro-2\|(2)_Fibroblasts / Cell class and subclass of bone marrow stroma cells in homeostatis	IGSF8 TRHDE ILDR2 MATN4 TLN2 PDLIM2	2.21e-05	190	132	6	d2afa08ad868acc6fce308ec21b0bf93591d4010
ToppCell	ASK428-Immune-NK_cell\|Immune / Donor, Lineage and Cell class of Lung cells from Dropseq	PRR5L HLA-A SLC38A5 PTCH1 PTPRCAP SLAMF7	2.21e-05	190	132	6	d649f7e17c4227787465dfc02037f791ff85378b
ToppCell	3'_v3-lymph-node_spleen-Lymphocytic_T_CD8-Tem/emra_CD8\|lymph-node_spleen / Manually curated celltypes from each tissue	PRR5L HLA-A HLA-F LAG3 RNF213 RASSF1	2.21e-05	190	132	6	66d29f53f129fc18771f6214316a913eeaccd55e
ToppCell	systemic_lupus_erythematosus-managed-Lymphocytic_T-CytoT_GZMH+-male\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	HLA-A LAG3 ATG2A PTPRCAP RASSF1 SLAMF7	2.27e-05	191	132	6	b2d0ea24970da09209da9d9dda76e30fbfe22917
ToppCell	10x5'-lymph-node_spleen-Lymphocytic_T_CD8-Trm/em_CD8\|lymph-node_spleen / Manually curated celltypes from each tissue	PRR5L HLA-A HLA-F LAG3 RNF213 SLAMF7	2.34e-05	192	132	6	7a122505d7adf236e0cbd9bcbc98e7c537600ca3
ToppCell	systemic_lupus_erythematosus-flare-Lymphocytic_T-CytoT_GZMK+-female\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	HLA-A LAG3 RNF213 ATG2A PTPRCAP SLAMF7	2.34e-05	192	132	6	ed1fb700d3e8f00495727d61e164fc0b70274fd0
ToppCell	3'_v3-lymph-node_spleen-Lymphocytic_T_CD8\|lymph-node_spleen / Manually curated celltypes from each tissue	PRR5L HLA-A HLA-F LAG3 RNF213 SLAMF7	2.34e-05	192	132	6	ab88ea7723f0fa3b39611981c043445f27425404
ToppCell	systemic_lupus_erythematosus-flare-Lymphocytic_T-CytoT_GZMK+\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	HLA-A LAG3 RNF213 ATG2A PTPRCAP SLAMF7	2.34e-05	192	132	6	6779b0294bb058e748e22b795b6a381c4add37e9
ToppCell	systemic_lupus_erythematosus-treated-Lymphocytic_T-CytoT_GZMH+-female\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	PRR5L HLA-A LAG3 RNF213 PTPRCAP SLAMF7	2.41e-05	193	132	6	d66cbb8c71bdc57faecb74a16fe3f34cb0b33228
ToppCell	IIH-CD8\|IIH / Condition, Cell_class and T cell subcluster	PRR5L HLA-A HLA-F LAG3 RNF213 SLAMF7	2.41e-05	193	132	6	343ac8c6dc6d7c7a944a14de65f1d4ea3dfafe86
ToppCell	systemic_lupus_erythematosus-treated-Lymphocytic_T-CytoT_GZMH+\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	PRR5L HLA-A LAG3 RNF213 PTPRCAP SLAMF7	2.41e-05	193	132	6	c1d9c2436503791350086a503d6b98c5c69f44ae
ToppCell	IIH-CD8-CD8_1\|IIH / Condition, Cell_class and T cell subcluster	PRR5L HLA-A HLA-F LAG3 RNF213 SLAMF7	2.41e-05	193	132	6	c5a4926003906d6726155f19061b73fb45d9962c
ToppCell	metastatic_Lymph_Node-T/NK_cells-Cytotoxic_CD8+_T\|metastatic_Lymph_Node / Location, Cell class and cell subclass	PRR5L HLA-A HLA-F LAG3 PTCH1 RASSF1	2.48e-05	194	132	6	73c057b623829de793616d9d373a0018071d51d8
ToppCell	367C-Lymphocytic-CD8+_Cytotoxic_T-cell\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	PRR5L LAG3 PTCH1 RGS3 RASSF1 SLAMF7	2.48e-05	194	132	6	a8dc3336aa4ef497f6d26cede02ddac425e7c655
ToppCell	BLOOD--(1)_EM_CTLs\| / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	PRR5L HLA-A HLA-F LAG3 RASSF1 SLAMF7	2.48e-05	194	132	6	66583c6cff3814902d6babdea3a2ae962decde65
ToppCell	10x_3'_v3-lymph_node_(10x_3'_v3)-lymphocytic-T_lymphocytic-CD8-positive,_alpha-beta_memory_T_cell\|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	PRR5L HLA-A HLA-F LAG3 SLAMF7 PDLIM2	2.48e-05	194	132	6	866a9ca4c93c3c79c709a9d00def5392197f7e18
ToppCell	systemic_lupus_erythematosus-flare-Lymphocytic_T-CytoT_GZMH+-female\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	PRR5L HLA-A LAG3 RNF213 PTPRCAP SLAMF7	2.48e-05	194	132	6	95ab357d5f7bf91ba287417928c8575e655814fc
ToppCell	(1)_T_cells-(1)_T_CD8_activated\|(1)_T_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1)	PRR5L HLA-A HLA-F LAG3 RNF213 SLAMF7	2.48e-05	194	132	6	e3f288b58525c1f34db4459d3e83e0df695adfc7
ToppCell	systemic_lupus_erythematosus-treated-Lymphocytic_NK\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	PRR5L HLA-A RNF213 RGS3 PTPRCAP SLAMF7	2.55e-05	195	132	6	ed41e709523cc3b86b1090d4fc0938ed47cb1fc9
ToppCell	control-Lymphocytic-CD8_T_cells\|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	PRR5L HLA-A HLA-F LAG3 RASSF1 SLAMF7	2.55e-05	195	132	6	55b9052336cab3e769a126ecaeef267d8e7bcaa8
ToppCell	systemic_lupus_erythematosus-flare-Lymphocytic_T-CytoT_GZMH+\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	PRR5L HLA-A LAG3 RNF213 PTPRCAP SLAMF7	2.55e-05	195	132	6	1a7c2c4cf30df435770794a989be438579bf98f2
ToppCell	healthy_donor-Lymphocytic-T_cell-CD8+_Memory_T_cell\|healthy_donor / Disease condition, Lineage, Cell class and subclass	PRR5L HLA-A LAG3 RNF213 PTPRCAP SLAMF7	2.63e-05	196	132	6	af00c31612e4fe068e5fccae05368edba46bbd20
ToppCell	10x_3'_v3-bone_marrow_(10x_3'_v3)-lymphocytic-T_lymphocytic-CD8-positive,_alpha-beta_T_cell\|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	PRR5L HLA-A HLA-F LAG3 PTPRCAP SLAMF7	2.63e-05	196	132	6	91902e135c05d1214d915c8d8e6037929c2501b8
ToppCell	10x5'-bone_marrow-Lymphocytic_T_CD8-Tem/emra_CD8\|bone_marrow / Manually curated celltypes from each tissue	HLA-A HLA-F LAG3 RNF213 ATG2A PTPRCAP	2.63e-05	196	132	6	f23c33ad10f933250be98e8389a9aa278e876f96
ToppCell	severe-CD8+_Tem\|World / disease stage, cell group and cell class	HLA-A HLA-F LAG3 ATG2A RASSF1 PDLIM2	2.63e-05	196	132	6	b8156d31312660fe9c071cb10d7ef22af672c6c8
ToppCell	(1)_T_cells-(1)_T_CD8_CytT\|(1)_T_cells / Lung cell shreds - cell class (v4) and cell subclass (v4)	PRR5L HLA-F LAG3 RGS3 RASSF1 SLAMF7	2.63e-05	196	132	6	3a4ba9ca84ce6b35038765da8c55812587b58bc2
Computational	Genes in the cancer module 293.	HLA-A HLA-F HLA-G	7.14e-05	12	76	3	MODULE_293
Computational	Neighborhood of RAP1B	SCAF8 HLA-F HLA-G RASSF1	1.15e-04	36	76	4	GNF2_RAP1B
Computational	Genes in the cancer module 143.	HLA-A HLA-F HLA-G	1.17e-04	14	76	3	MODULE_143
Disease	graft-versus-host disease (implicated_via_orthology)	HLA-A HLA-F HLA-G	2.38e-06	7	122	3	DOID:0081267 (implicated_via_orthology)
Disease	Malignant neoplasm of breast	NID2 ADAT3 SRSF1 OBSCN XDH MANEA H6PD SIX4 TRIM29 HPSE PLD2 KAT6B VPS13B PLXNB1	1.46e-04	1074	122	14	C0006142
Disease	Moyamoya disease (is_implicated_in)	HLA-A RNF213	1.68e-04	5	122	2	DOID:13099 (is_implicated_in)
Disease	Strabismus	ADARB2 RGS3 CSMD1	2.33e-04	29	122	3	HP_0000486
Disease	Hyperuricemia	XDH ALDH16A1	3.51e-04	7	122	2	C0740394
Disease	Nerve Degeneration	NTF4 XDH IGF2 NOS1	3.97e-04	83	122	4	C0027746
Disease	Parkinson Disease	ADARB2 IGF2 NOS1 SLC30A10	4.35e-04	85	122	4	C0030567
Disease	Gout	XDH ALDH16A1	5.99e-04	9	122	2	C0018099
Disease	neurotic disorder	PTCH1 RASSF1 CSMD1 NOS1	8.34e-04	101	122	4	EFO_0004257
Disease	Paranoia	HLA-A MANEA	9.10e-04	11	122	2	C1456784
Disease	eosinophil measurement	HLA-A RASSF1 TIMM29 CLEC16A	1.07e-03	108	122	4	EFO_0803540
Disease	squamous cell carcinoma, multiple keratinocyte carcinoma susceptibility measurement, basal cell carcinoma	TMCC3 CSMD1	1.28e-03	13	122	2	EFO_0000707, EFO_0004193, EFO_0007932
Disease	cataract (biomarker_via_orthology)	XDH CRYBA4	1.28e-03	13	122	2	DOID:83 (biomarker_via_orthology)
Disease	cortisol measurement, response to corticosteroid, response to synacthen	NOS1 PDE7B	1.28e-03	13	122	2	EFO_0005843, EFO_0009175, GO_0031960
Disease	aspartate aminotransferase measurement	HLA-A OBSCN XDH RNF213 MANEA PTCH1 P2RY2 CSMD1 CLEC16A PDE7B SLC30A10	1.34e-03	904	122	11	EFO_0004736
Disease	behavior	SLCO3A1 PTCH1 NOS1	1.55e-03	55	122	3	GO_0007610
Disease	Hypertrophic Cardiomyopathy	MYOM1 OBSCN RASSF1	1.71e-03	57	122	3	C0007194
Disease	impotence (implicated_via_orthology)	P2RY2 NOS1	1.72e-03	15	122	2	DOID:1875 (implicated_via_orthology)
Disease	unipolar depression, cognitive function measurement	DCAF6 ADAMTS5	1.72e-03	15	122	2	EFO_0003761, EFO_0008354
Disease	Rhabdomyosarcoma	PTCH1 IGF2	1.72e-03	15	122	2	C0035412
Disease	Eczema, allergic rhinitis	PITPNM2 PRR5L HLA-A HCG22 CLEC16A	2.04e-03	215	122	5	EFO_0005854, HP_0000964
Disease	serum dimethylarginine measurement	MYOM1 SLCO3A1 MANEA	2.29e-03	63	122	3	EFO_0005418
Disease	Tourette syndrome, schizophrenia	PITPNM2 DNAH10	2.48e-03	18	122	2	EFO_0004895, MONDO_0005090
Disease	schizophrenia (implicated_via_orthology)	SHMT2 CSMD1 NOS1	2.84e-03	68	122	3	DOID:5419 (implicated_via_orthology)
Disease	sphingomyelin 22:0 measurement	CSMD1 PDE7B	3.07e-03	20	122	2	EFO_0010395
Disease	cerebellum white matter volume change measurement, age at assessment	TRHDE SLC30A10	3.07e-03	20	122	2	EFO_0008007, EFO_0021498
Disease	osteoarthritis (biomarker_via_orthology)	ADAMTS5 TNFRSF10D	3.38e-03	21	122	2	DOID:8398 (biomarker_via_orthology)
Disease	serum IgM measurement	HLA-G SLAMF7	3.71e-03	22	122	2	EFO_0004993
Disease	asthma	DCAF1 PITPNM2 PRR5L SCAF8 TNFRSF10D PTCH1 VWA7 CLEC16A CDK2	4.06e-03	751	122	9	MONDO_0004979
Disease	reticulocyte count	PITPNM2 NUDT14 HLA-A DNAH10 HLA-G PLXNB2 IGF2 P2RY2 RASSF1 TLN2 SLC30A10	4.10e-03	1045	122	11	EFO_0007986

Protein segments in the cluster

Peptide	Gene	Start	Entry
ARPDAIRRGSGDYAL	TRHDE	356	Q9UKU6
LVARGQGRGTYDFRP	ADAT3	231	Q96EY9
DARGLTPLAYARRAG	AGAP3	816	Q96P47
SRSAFLTGRYPIRSG	ARSF	81	P54793
FGLARVFSPDGSRLY	CDK20	146	Q8IZL9
GPGAYFSRKARLSFR	C17orf114	51	A0A1B0GUV1
DAISYRFPRGVSRSL	CNTNAP1	181	P78357
EPRYGRRIGSEFSAG	CSMD1	1746	Q96PZ7
AGPRAREIFTSLEYG	ALDH16A1	6	Q8IZ83
QRGYVPSGFLARARS	ARHGEF37	651	A1IGU5
PAEALRTLRIGGFYA	SMPD1	356	P17405
FYRGTVDGSPRSLAV	ADAMTS5	131	Q9UNA0
ATRRYPAAGIGFVFL	CT47B1	111	P0C2W7
GREGPLSASVLFEYR	CAMTA2	601	O94983
AASSRPRRGIIFYHG	AADACL4	106	Q5VUY2
RSRGYFRIDSATGAV	CELSR1	291	Q9NYQ6
EFGARVPRTGSAYLF	SLC7A4	91	O43246
GARYRAGPGDRRSAV	DCAF6	666	Q58WW2
VRDGYFSRPIGSTDL	ATG2A	1391	Q2TAZ0
SPRKGSFTAGRAREY	ADAMTS13	556	Q76LX8
EIPGGRRALFDSYTN	ABI2	11	Q9NYB9
AAGGSPLRQYFFETR	NTF4	126	P34130
PGRGTSVRRRTSFYL	RASSF1	196	Q9NS23
PGDAALLSAAYGRRR	ADARB2	241	Q9NS39
SGAQDSLPFGRRLYS	RGS3	56	P49796
PLTFRIDRGRYGLDS	RNF130	51	Q86XS8
LRYFSTAVSRPGRGE	HLA-F	26	P30511
AGARSGYRGRRSPHT	P3H3	491	Q8IVL6
FRPRLIIAGTSAYAR	SHMT2	216	P34897
TDGAPAYSIYGRPRR	ODF3B	81	A8MYP8
GSARIPFRVGLYTGE	PCDHA2	616	Q9Y5H9
FSYLLSRREGQAGSP	KAT6B	876	Q8WYB5
YFSAAVSRPGRGEPR	HLA-G	31	P17693
RVLIGSSFYPSAEGR	PADI6	436	Q6TGC4
TSRLNRRASFPKYGG	DCAF1	1051	Q9Y4B6
DRLGLYPRFDSAGRS	HYAL2	81	Q12891
TLSYRASGVPDRFSG	IGKV2D-40	76	P01614
SSRVRTEFPLGRYGT	MATN4	431	O95460
RTLIPRYFRSIFEGG	LDB1	121	Q86U70
PRRSGLSAGHRDVFY	MBD3	21	O95983
YAGEVERRFPGSLAA	NUDT14	66	O95848
GLGASRPRVAVRSAY	KRT7	41	P08729
RRRYATPASALAGES	LRRC53	481	A6NM62
ASSRKRTPAAGGFFR	JPH4	206	Q96JJ6
SGIRFIYTREGRPSG	HNRNPH2	41	P55795
AGEPLLFVGRGYTSR	PLXNB1	161	O43157
APGSGRVLYAVFSRD	PLXNB2	286	O15031
RAFEPLRSFASGGRS	PLXNB2	986	O15031
TGVRAERRGSYPFID	PDE7B	36	Q9NP56
EYGAAFRAGLPRDLT	KCNH4	671	Q9UQ05
RRLGSFYGSFASPDL	LRP3	256	O75074
GDAARTLGPRVFGRY	LIAS	6	O43766
GSAAFRARGRTLEPY	GGACT	26	Q9BVM4
YFTELSSPGAQRSGR	LAG3	426	P18627
GLYRQGAPEFRVASS	PITPNM2	386	Q9BZ72
APVLYFVTTSARGGR	P2RY2	166	P41231
RTLARGLSPAYLRFG	HPSE	81	Q9Y251
GSRSIRNSPYDGLFI	MANEA	286	Q5SRI9
NVRFSVFGLGSRAYP	NOS1	881	P29475
SDRASPERRYGIVGL	HCG22	51	E2RYF7
GDRSFSGPTYTLARR	PRR5L	226	Q6MZQ0
SFGPSGRRGRQTYTR	HOXB6	141	P17509
LAPGETYRFRVAAVG	OBSCN	4586	Q5VST9
AARYVRAGFPRSARF	NID2	136	Q14112
GFYRDPGRALSDRRA	NTN3	356	O00634
FGLARAFGVPLRTYT	CDK3	146	Q00526
LGYTRDSPGFLRFVR	HECTD1	2511	Q9ULT8
LRLEAARPGDAGTYR	IGSF8	391	Q969P0
DTLLGDPARRGRFYD	KCNA7	36	Q96RP8
TPDVRARLAAGFYGS	LACTBL1	221	A8MY62
RELNRFDGSGPYSTL	DNASE1L1	71	P49184
DVAEFSSRYGPGQRR	DDX51	531	Q8N8A6
GDSFVRLRVPAAYAG	FCGBP	2191	Q9Y6R7
YEEPGRAGRSFTREI	EPHA8	616	P29322
GPEAGDFLARYRLVS	F8A1;	16	P23610
GDRGFYFSRPASRVS	IGF2	46	P01344
FLTYFPGRRISAEDG	CDK11A	691	Q9UQ88
GGNTAYPAERLTSFR	CRYBA4	81	P53673
YFFTSVSRPGRGEPR	HLA-A	31	P04439
ERFAGRPTQRVSGLY	DMGDH	461	Q9UI17
SITFLPRGRGDYAQF	CEP192	2351	Q8TEP8
PRTYLTYRRAAEGAG	DENND4B	141	O75064
SARFVPRYNFTRGDL	HS6ST2	201	Q96MM7
TLSYRASGVPDRFSG	IGKV2-40	76	A0A087WW87
FGLARAFGVPVRTYT	CDK2	146	P24941
AGLREAGRIFYFSVP	H6PD	131	O95479
DGYRPAARRGAILFF	DNAH10	3646	Q8IVF4
GRFRSGNYRFDPRSG	SCAF8	1121	Q9UPN6
RDRSSGYPLTIEGFA	HNRNPUL1	226	Q9BUJ2
TGNFPLRRISAARYG	TMEM67	201	Q5HYA8
YGLTPRGRNRSTVFS	GRIN3B	601	O60391
LTYGEVSGREDRPFR	RPUSD1	191	Q9UJJ7
GETRRNSYPRADTGL	TRIM29	146	Q14134
AEARARPGRAAVYVG	TIMM29	51	Q9BSF4
RPEASARAYGGSATI	TMCC3	231	Q9ULS5
VSYFGARGHRPRLIG	SLCO3A1	96	Q9UIG8
YLSPARRRFGGDATF	FAM83E	441	Q2M2I3
AVGYRQEREGFLPSR	SLC38A5	16	Q8WUX1
PGYAASIRRTDGGLF	PIWIL2	361	Q8TC59
TERRAFRPYGLHGGE	OPLAH	1196	O14841
RLSRDSGGYYHPARL	PTPRCAP	56	Q14761
YRSLAGRAPAGAAAV	GDF7	96	Q7Z4P5
GVRTVYRFANRTGFP	NCAN	331	O14594
AALPRFFRGATELYR	HS2ST1	266	Q7LGA3
TGGLRRAAAPDRDYL	PTCH1	36	Q13635
YTEAERARGRPLGAV	SIX4	191	Q9UIU6
EVFHYGSLRGRSRRP	ST6GALNAC6	66	Q969X2
GDGGRSRYEFTLPRA	SHISA7	391	A6NL88
AADRLSYSGRPGSRQ	PDLIM2	166	Q96JY6
LPFRFYDQGRRGSSD	CLEC16A	851	Q2KHT3
AAGYISREPGRRGAD	C11orf96	211	Q7Z7L8
ASSARAGRYPGARTA	TNFRSF10D	11	Q9UBN6
GHDFRPDYLRLGALR	RECQL5	166	O94762
EGRFLKAYSPASRGR	RNF213	4201	Q63HN8
YSGSFARDAVAVRPG	TNRC18	591	O15417
GGHQFLRSPYRSVRF	VWDE	26	Q8N2E2
SAGYIARRPTRGFSA	SLC30A10	56	Q6XR72
AVGASGPFVRLYDIR	WDTC1	201	Q8N5D0
AEFLALGRYRAAPGR	USP43	126	Q70EL4
LGRYRAAPGRAEVTE	USP43	131	Q70EL4
VAGTERSRFLGPQYF	STAG3	1141	Q9UJ98
AAFADSYGQRPRRAD	ILDR2	431	Q71H61
GRLLVTFEPRRYGSA	IGHMBP2	61	P38935
YAREGAARPAASLGT	USP35	866	Q9P2H5
LRNGGSPAFYTAFRS	TEX13C	26	A0A0J9YWL9
TGYRPILQGFRTFAR	XDH	151	P47989
LTRADSGYLFSGSRP	TMEM201	461	Q5SNT2
RNRERVDFPDGGYSL	SLAMF7	76	Q9NQ25
YESRQRRYLGSSPEG	TRIM17	311	Q9Y577
VADFFRLPYEGLTRG	VPS13B	3671	Q7Z7G8
FASRGEPIGRYDQAT	TLN2	791	Q9Y4G6
GYRLRVEFPRSGRGT	SRSF1	81	Q07955
YFGPGSSRRFRAALG	VWA7	91	Q9Y334
LARFAVAYSPARDAG	PLD2	126	O14939
AGSAYFRSLFAAGRP	KLHL35	61	Q6PF15
FARFPVTGLIEGRSY	MYOM1	566	P52179